Card image cap
Barrons reported "Aurora Cannabis Stock Can Surge With New Partnerships, Analyst Says" on Friday

[] Azer spoke with Aurora’s Chief Corporate Officer Cam Battley following the news, and writes that Peltz should help open a number of doors for ACB as they develop their next legs of growth She also thinks that the structure of Peltz’s compensationhis options for 20 million shares vest over four years, with various incentivesbodes well, and the arrangement is a win-win for both parties Cowen & Co.’s Vivien Azer reiterated an Outperform rating on the marijuana stock, and says the new partnership with Nelson Peltz will “help accelerate performance.”

Open Original Source

Share Original Source

Similar posts

Aurora Cannabis Stock Can Surge With New Partnerships, Analyst Says

Aurora Cannabis Stock Can Surge With New Partnerships, Analyst Says

Gilead Stock Could Surge to $84, Says Analyst

Gilead Stock Could Surge to $84, Says Analyst

Gilead Stock Could Surge to $84, Says Analyst Yet today, with the shares up just 3% year to date, Gilead’s position is lonelier, as the SPDR S&P Biotech ETF (XBI) and the iShares Nasdaq Biotechnology ETF (IBB) are both up double digits in 2019 He points to the recent data about its injectable HIV capsid inhibitor (a treatment that seeks to interfere with an enzyme or protein that HIV-infected cells need to make new viruses)